Phone: 866.839.4840 | Fax: 732.905.7893

December 2012

Posted on: December 4th, 2012 by Martek Pharmacal


HAPPY HOLIDAYS!

 The office will be closed for the Christmas and New Year holidays on the following dates:

Monday, December 24 and Tuesday, December 25
Monday, December 31 and Tuesday, January 1
During the holiday season we want to remind our customers that this is the busiest time of the year for the transportation industry.  From Thanksgiving until the end of the year, UPS suspends their time-in-transit delivery guarantee.   We suggest you place your order now to ensure your shipment is received in a timely manner.

Lannett has discontinued manufacturing Hydrochlorathiazide 25mg and 50mg tablets.  We still have a good supply of their product in stock, but are currently negotiating with another manufacturer.

 

Posted in Uncategorized | Comments Off on December 2012

November 2012

Posted on: November 3rd, 2012 by Martek Pharmacal


We would like to thank all of our customers for their support during the Hurricane Sandy Crisis!  Your phone calls and emails are sincerely appreciated.  Our families are doing well, with no injuries or property damage.  We were very fortunate, compared to what has happened to some of  our friends and neighbors .
Despite the chaos of the last week, we were still able to complete our relocation to our larger facility.  Our new company information is as follows:
Martek Pharmacal Co.
575 Prospect Street  Unit 213
Lakewood, NJ 08701
732-905-7891 phone
732-905-7893 fax
866-839-4840 toll free phone
Please send all future remittance to this address, and please update the address for any automatic bank payments.  Our toll free number has not changed, but please make note of our new fax number.
Due to the significant cost of the new combination weight loss medication, Qsymia, several of our customers have inquired about dispensing the two generic medications, Phentermine and Topiramate.   We carry both of these products and will be happy to discuss these medications with you.   
Posted in Uncategorized | Comments Off on November 2012

October 2012

Posted on: October 9th, 2012 by Martek Pharmacal

We have still not received distribution information on the two new diet medications, Qsymia and Belviq. We are anticipating that these new medications will be extremely expensive when they do finally become available.

Our October/November product flier was mailed to our customers during the last week of September. Please contact us if you have not received this flier.

We will be exhibiting our products at the 62nd annual ASBP symposium in Orlando, Florida on October 25th and 26th. If you are attending, please stop by booth #207 and say hello.

Posted in Uncategorized | Comments Off on October 2012

August 2012

Posted on: August 14th, 2012 by Martek Pharmacal

The FDA has approved the new weight loss drug Qsymia (formerly known as Qnexa).   At this time, product availability and pricing information has not been released.  We are still waiting for the same information on the other approved weight loss drug, Belviq.
Our July/August product specials are still in effect.  Please call us if you need a copy of that flier.
Posted in Uncategorized | Comments Off on August 2012

Posted on: July 2nd, 2012 by Martek Pharmacal

July 2012

The FDA approved the new weight loss drug, Belviq (Lorcaserin Hydrochloride). 
Belviq works by activating the serotonin 2C receptor in the brain. Activation of this receptor may help a person eat less and feel full after eating smaller amounts of food.  We will advise our customers regarding price and availability as soon as the information becomes available.
The FDA has delayed its decision to approve the weight loss drug, Qnexa.  The target date has been pushed back to July 17 to consider a new drug safety plan submitted by the manufacturer, Vivus.   Previously, the agency was scheduled to make a decision by April 17.  Vivus stated the three-month extension is standard when companies submit additional risk management information for a drug. 
Akrimax Pharmaceuticals is currently manufacturing Phentermine Hydrochloride 15mg and 30mg tablets.  Their products are orally disintegrating tablets (ODT) and can be taken with or without water.   Akrimax is marketing their Phentermine as “Brand” items under the name Suprenza.  Please contact us for additional product information.
Sandoz is now manufacturing Phentermine 15mg gray/yellow capsules and Phentermine 30mg yellow capsules.  We carry both products in 1000ct bottles only.
Our July/August flier will be mailed the week of July 9th.  We were waiting for information regarding the new weight loss drug, Belviq, but have not yet heard about  availability and price of this medication.
Posted in Uncategorized | Comments Off on

Posted on: June 4th, 2012 by Martek Pharmacal

June 2012
Akrimax Pharmaceuticals is currently manufacturing Phentermine Hydrochloride 15mg and 30mg tablets.  Their products are orally disintegrating tablets (ODT) and can be taken with or without water.   Akrimax is marketing their Phentermine as “Brand” items under the name Suprenza.  Please contact us for additional product and price information.
The FDA has delayed its decision to approve the weight loss drug, Qnexa.  The target date has been pushed back to July 17 to consider a new drug safety plan submitted by the manufacturer, Vivus.   Previously the agency was scheduled to make a decision by April 17.  Vivus stated the three-month extension is standard when companies submit additional risk management information for a drug.
We are now completely out of the Bontril 35mg tablets and 105mg capsules.  If you were using these products, please contact us to discuss the generic alternatives.
Posted in Uncategorized | Comments Off on

Posted on: May 7th, 2012 by Martek Pharmacal

The FDA has delayed its decision to approve the weight loss drug, Qnexa.  The target date has been pushed back to July 17 to consider a new drug safety plan submitted by the manufacturer, Vivus.   Previously the agency was scheduled to make a decision by April 17.  Vivus stated the three-month extension is standard when companies submit additional risk management information for a drug.
We are now completely out of the Bontril 35mg tablets and 105mg capsules.  If you were using these products, please contact us to discuss the generic alternatives.
Posted in Uncategorized | Comments Off on

April 2012

Posted on: April 2nd, 2012 by Martek Pharmacal

Our April/May product flier has just been mailed to our customers. Please contact us if you have not received our flier by the tenth of this month and we will fax or email a copy to you.

We have a limited supply of 100ct bottles of the Phendimetrazine (Bontril) 35mg green/yellow tablets. As mentioned in our flier, Valeant has discontinued production of the Phendimetrazine 35mg tablets and 105mg capsules.

Actavis announced they are going to resume production of their Phendimetrazine and Phentermine products. They expect to begin manufacturing their Phendimetrazine 35mg yellow tablets during April. We do not have a time frame yet for their Phentermine products.

We now have the Lannett Phentermine 15mg gray/yellow capsules available in 100ct and 1000ct bottles.

Posted in Uncategorized | Comments Off on April 2012

March 2012

Posted on: March 8th, 2012 by Martek Pharmacal

The FDA panel recently recommended that the FDA give approval to the new weight loss drug Qnexa. Although the FDA isn’t required to follow the recommendations of its special panels, it often does. The FDA expects to make their final decision by the end of April. Qnexa is a combination of Phentermine and Topamax (Topiramate). Both of the medications are available separately as generic. If Qnexa ends up being approved, the FDA scientists said they would require Vivus, the manufacturer, to train prescribers to educate patients on the pregnancy risks of Qnexa. Only 10 mail-order pharmacies would be permitted to sell the drug. We will advise our customers as we learn more information about product availability.

Lannett will begin manufacturing Phentermine 15mg gray/yellow capsules. We expect to receive our first shipment the week of March 19. Please give us a call for pricing on this new product.

Posted in Uncategorized | Comments Off on March 2012

February 2012

Posted on: February 7th, 2012 by Martek Pharmacal

Valeant claims they will continue to manufacture the Phendimetrazine (Bontril) 35mg Green/Yellow layered tablets in 100ct bottles only. Unfortunately they have tripled their price on this product. We still have a limited supply at the original 100ct price. Due to the significant price increase, once our stock is depleted, we will only bring more in by request of our customers.

We have a number of short-dated products in stock at reduced prices. Please contact us for more information on these specials.

Posted in Uncategorized | Comments Off on February 2012